MECHANISMS OF HIGH-LEVEL RESISTANCE TO QUINOLONES IN URINARY-TRACT ISOLATES OF PSEUDOMONAS-AERUGINOSA

被引:38
作者
YOSHIDA, T
MURATANI, T
IYOBE, S
MITSUHASHI, S
机构
[1] EPISOME INST,FUJIMI,GUNMA 37101,JAPAN
[2] GUNMA UNIV,SCH MED,DRUG RESISTANCE BACTERIA LAB,MAEBASHI,GUMMA 371,JAPAN
关键词
D O I
10.1128/AAC.38.7.1466
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Twenty-eight strains of Pseudomonas aeruginosa with various degrees of norfloxacin resistance were isolated from patients with urinary tract infections. P. aeruginosa strains (norfloxacin MICs, 3.13 to 200 mu g/ml) were transformed by either pPAW207 or pNF111 plasmid DNA, which included either the gyrA or nfxB gene, respectively. For transformants with pPAW207, norfloxacin MICs decreased 8- to 128-fold. It was suggested that moderate and high degrees of resistance to norfloxacin were expressed as a result of alterations in gyrA. No strain manifesting only an alteration in nfxB permeability was observed. The MICs of norfloxacin (200 mu g/ml) for two P. aeruginosa strains, GN17605 and GN17434-2, were decreased following transformation not only by pPAW207 but also by pNF111. Analysis of outer membrane proteins disclosed the presence of a 54,000-Da protein in these parent strains that was not expressed in the pNF111 transformants. The level of accumulation of norfloxacin by the pNF111 transformant of GN17605 was higher than that by the parent strain. The norfloxacin susceptibility of DNA gyrase subunit A purified from GN17605 was only 1/35th that of the gyrase containing a subunit A from P. aeruginosa PAO1. These findings suggest that GN17605 is a gyrA-nfxB double mutant and that strain GN17434-2 possesses double mutations in both nfxB and some unknown gene.
引用
收藏
页码:1466 / 1469
页数:4
相关论文
共 19 条
[1]   CHARACTERIZATION OF MECHANISMS OF QUINOLONE RESISTANCE IN PSEUDOMONAS-AERUGINOSA STRAINS ISOLATED INVITRO AND INVIVO DURING EXPERIMENTAL ENDOCARDITIS [J].
CHAMBERLAND, S ;
BAYER, AS ;
SCHOLLAARDT, T ;
WONG, SA ;
BRYAN, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :624-634
[2]   INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF T-3262, A NEW FLUOROQUINOLONE [J].
FUJIMAKI, K ;
NOUMI, T ;
SAIKAWA, I ;
INOUE, M ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (06) :827-833
[3]   NEW NORFLOXACIN RESISTANCE GENE IN PSEUDOMONAS-AERUGINOSA PAO [J].
FUKUDA, H ;
HOSAKA, M ;
HIRAI, K ;
IYOBE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1757-1761
[4]   CROSS-RESISTANCE TO NALIDIXIC-ACID, TRIMETHOPRIM, AND CHLORAMPHENICOL ASSOCIATED WITH ALTERATIONS IN OUTER-MEMBRANE PROTEINS OF KLEBSIELLA, ENTEROBACTER, AND SERRATIA [J].
GUTMANN, L ;
WILLIAMSON, R ;
MOREAU, N ;
KITZIS, MD ;
COLLATZ, E ;
ACAR, JF ;
GOLDSTEIN, FW .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :501-507
[5]   MUTATIONS PRODUCING RESISTANCE TO NORFLOXACIN IN PSEUDOMONAS-AERUGINOSA [J].
HIRAI, K ;
SUZUE, S ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) :582-586
[6]   DIFFERENCES IN SUSCEPTIBILITY TO QUINOLONES OF OUTER-MEMBRANE MUTANTS OF SALMONELLA-TYPHIMURIUM AND ESCHERICHIA-COLI [J].
HIRAI, K ;
AOYAMA, H ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) :535-538
[7]   SOME PROPERTIES OF SUBUNITS OF DNA GYRASE FROM PSEUDOMONAS-AERUGINOSA PA01 AND ITS NALIDIXIC ACID-RESISTANT MUTANT [J].
INOUE, Y ;
SATO, K ;
FUJII, T ;
HIRAI, K ;
INOUE, M ;
IYOBE, S ;
MITSUHASHI, S .
JOURNAL OF BACTERIOLOGY, 1987, 169 (05) :2322-2325
[8]   OCCURRENCE OF THE NFXB TYPE MUTATION IN CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA [J].
JAKICS, EB ;
IYOBE, S ;
HIRAI, K ;
FUKUDA, H ;
HASHIMOTO, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (11) :2562-2565
[9]   PLASMID-MEDIATED GENTAMICIN RESISTANCE OF PSEUDOMONAS-AERUGINOSA AND ITS LACK OF EXPRESSION IN ESCHERICHIA-COLI [J].
KATO, T ;
SATO, Y ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (03) :358-363
[10]   LIPOPOLYSACCHARIDE ALTERATIONS RESPONSIBLE FOR COMBINED QUINOLONE AND BETA-LACTAM RESISTANCE IN PSEUDOMONAS-AERUGINOSA [J].
LEYING, HJ ;
BUSCHER, KH ;
CULLMANN, W ;
THEN, RL .
CHEMOTHERAPY, 1992, 38 (02) :82-91